Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanjun Bao

Showing results (21-30 of 80) with videos related to

Pageof 8
Sort By:
Nanophotonics (Berlin, Germany)|March 9, 2026
Metasurface Vision Transformer: A Generic AI Model for Metasurface Inverse DesignJiahao Yan, Jilong Yi, Churong Ma, et al.
Dalton Transactions (Cambridge, England : 2003)|August 9, 2016
Highly efficient phosphorescent materials based on Ir(iii) complexes-grafted on a polyhedral oligomeric silsesquioxane coreTianzhi Yu, Zixuan Xu, Wenming Su, et al.
Preventive Medicine|September 26, 2006
Food store availability and neighborhood characteristics in the United StatesLisa M Powell, Sandy Slater, Donka Mirtcheva, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 10, 2018
Effect of ombitasvir/paritaprevir/ritonavir + dasabuvir regimen on health-related quality of life for patients with hepatitis CSammy Saab, Darshan Mehta, Stacie Hudgens, et al.
Nanophotonics (Berlin, Germany)|September 19, 2025
Dual-mode varifocal Moiré metalens for quantitative phase and edge-enhanced imagingYi Lian, Yongqi Liu, Dewen Cheng, et al.
Nature Communications|December 8, 2022
Observation of full-parameter Jones matrix in bilayer metasurfaceYanjun Bao, Fan Nan, Jiahao Yan, et al.
RMD Open|November 5, 2015
Longer durations of antitumour necrosis factor treatment are associated with reduced risk of cardiovascular events in patients with rheumatoid arthritisMichael Nurmohamed, Yanjun Bao, James Signorovitch, et al.
Clinicoeconomics and Outcomes Research : CEOR|August 18, 2017
Clinical and economic analysis of outcomes of dose tapering or withdrawal of tumor necrosis factor-α inhibitors upon achieving stable disease activity in rheumatoid arthritis patientsDaniel Aletaha, Sonya J Snedecor, Varun Ektare, et al.
Current Medical Research and Opinion|September 26, 2014
Comparing the risk of developing uveitis in patients initiating anti-tumor necrosis factor therapy for ankylosing spondylitis: an analysis of a large US claims databaseDaniel Wendling, Avani Joshi, Patrick Reilly, et al.
Clinical Rheumatology|March 19, 2016
Ankylosing spondylitis diagnosis in US patients with back pain: identifying providers involved and factors associated with rheumatology referral delayAtul Deodhar, Manish Mittal, Patrick Reilly, et al.
Pageof 8

Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
Nanophotonics (Berlin, Germany)|March 9, 2026
Metasurface Vision Transformer: A Generic AI Model for Metasurface Inverse DesignJiahao Yan, Jilong Yi, Churong Ma, et al.
Dalton Transactions (Cambridge, England : 2003)|August 9, 2016
Highly efficient phosphorescent materials based on Ir(iii) complexes-grafted on a polyhedral oligomeric silsesquioxane coreTianzhi Yu, Zixuan Xu, Wenming Su, et al.
Preventive Medicine|September 26, 2006
Food store availability and neighborhood characteristics in the United StatesLisa M Powell, Sandy Slater, Donka Mirtcheva, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 10, 2018
Effect of ombitasvir/paritaprevir/ritonavir + dasabuvir regimen on health-related quality of life for patients with hepatitis CSammy Saab, Darshan Mehta, Stacie Hudgens, et al.
Nanophotonics (Berlin, Germany)|September 19, 2025
Dual-mode varifocal Moiré metalens for quantitative phase and edge-enhanced imagingYi Lian, Yongqi Liu, Dewen Cheng, et al.
Nature Communications|December 8, 2022
Observation of full-parameter Jones matrix in bilayer metasurfaceYanjun Bao, Fan Nan, Jiahao Yan, et al.
RMD Open|November 5, 2015
Longer durations of antitumour necrosis factor treatment are associated with reduced risk of cardiovascular events in patients with rheumatoid arthritisMichael Nurmohamed, Yanjun Bao, James Signorovitch, et al.
Clinicoeconomics and Outcomes Research : CEOR|August 18, 2017
Clinical and economic analysis of outcomes of dose tapering or withdrawal of tumor necrosis factor-α inhibitors upon achieving stable disease activity in rheumatoid arthritis patientsDaniel Aletaha, Sonya J Snedecor, Varun Ektare, et al.
Current Medical Research and Opinion|September 26, 2014
Comparing the risk of developing uveitis in patients initiating anti-tumor necrosis factor therapy for ankylosing spondylitis: an analysis of a large US claims databaseDaniel Wendling, Avani Joshi, Patrick Reilly, et al.
Clinical Rheumatology|March 19, 2016
Ankylosing spondylitis diagnosis in US patients with back pain: identifying providers involved and factors associated with rheumatology referral delayAtul Deodhar, Manish Mittal, Patrick Reilly, et al.
Pageof 8